Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.

Satu Koivula, Minna Taskinen, Ping Chen, Harald Holte, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Magnus Bjorkholm, Oystein Fluge, Lars Moller Pedersen, Mats Jerkeman, Mikael Eriksson, Sampsa Hautaniemi, Sirpa Leppa

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Issue number21
Pages (from-to)1281-1281
Number of pages1
Publication statusPublished - 19 Nov 2010
Event52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando
Duration: 4 Dec 20107 Dec 2010

Cite this